Arkolith/Insider Trading/LBRX/Form 4

Nussbaum Ran

DirectorLB PHARMACEUTICALS INC (LBRX) · full profile →Form 4 · filed Sep 16, 2025
Net Buying
Open-Market Buys
$15.0M
Open-Market Sells
$0
Net Open-Market Flow
$15.0M
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 12, 2025Conversion(C)412K——412K
Sep 12, 2025Buy(P)1.0M$15.00$15.0M1.4M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 12, 2025Conversion(C)10.0M——0

Transaction Codes

C
Conversion of a derivative
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001609805-25-000006) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML